Convergence Investment Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,725
| Closed | -$289K | – | 285 |
|
|
2021
Q1 | $289K | Buy |
+1,725
| New | +$289K | 0.13% | 159 |
|
|
2020
Q4 | – | Sell |
-9,575
| Closed | -$967K | – | 284 |
|
|
2020
Q3 | $967K | Buy |
9,575
+5,367
| +128% | +$542K | 0.34% | 110 |
|
|
2020
Q2 | $509K | Buy |
+4,208
| New | +$509K | 0.18% | 173 |
|
|
2018
Q4 | – | Sell |
-6,754
| Closed | -$864K | – | 373 |
|
|
2018
Q3 | $864K | Buy |
6,754
+2,294
| +51% | +$293K | 0.18% | 163 |
|
|
2018
Q2 | $505K | Buy |
4,460
+4,311
| +2,893% | +$488K | 0.07% | 259 |
|
|
2018
Q1 | $17K | Buy |
+149
| New | +$17K | ﹤0.01% | 627 |
|
|
2017
Q3 | – | Sell |
-17,230
| Closed | -$2.24M | – | 399 |
|
|
2017
Q2 | $2.24M | Sell |
17,230
-656
| -4% | -$85.1K | 0.33% | 115 |
|
|
2017
Q1 | $2.42M | Buy |
17,886
+86
| +0.5% | +$11.6K | 0.34% | 114 |
|
|
2016
Q4 | $2.55M | Buy |
17,800
+9,220
| +107% | +$1.32M | 0.35% | 105 |
|
|
2016
Q3 | $1.01M | Buy |
8,580
+6,486
| +310% | +$766K | 0.15% | 238 |
|
|
2016
Q2 | $222K | Sell |
2,094
-22,365
| -91% | -$2.37M | 0.03% | 302 |
|
|
2016
Q1 | $2.73M | Buy |
24,459
+3,334
| +16% | +$371K | 0.32% | 108 |
|
|
2015
Q4 | $3.31M | Buy |
21,125
+5,150
| +32% | +$806K | 0.37% | 98 |
|
|
2015
Q3 | $2.1M | Buy |
15,975
+7,325
| +85% | +$962K | 0.24% | 147 |
|
|
2015
Q2 | $1.51M | Buy |
+8,650
| New | +$1.51M | 0.15% | 220 |
|
|
2014
Q3 | – | Sell |
-10,760
| Closed | -$952K | – | 430 |
|
|
2014
Q2 | $952K | Buy |
+10,760
| New | +$952K | 0.13% | 244 |
|
|
2014
Q1 | – | Sell |
-30,555
| Closed | -$3.46M | – | 434 |
|
|
2013
Q4 | $3.46M | Sell |
30,555
-580
| -2% | -$65.6K | 0.56% | 36 |
|
|
2013
Q3 | $2.46M | Buy |
31,135
+4,435
| +17% | +$350K | 0.52% | 51 |
|
|
2013
Q2 | $1.76M | Buy |
+26,700
| New | +$1.76M | 0.46% | 72 |
|